Inhibition of Histamine Release from RBL-2H3 Cells by Zoledronate Did Not Affect Rab27a/Doc2a Interaction

Area of Science:

• Cell Biology
• Immunology
• Pharmacology

Background:

• Mast cell (MC) exocytosis relies on prenylated proteins, including Rab family members like Rab3a, Rab27a, and Rab11.
• Bisphosphonates, such as zoledronate, can disrupt prenylation, potentially affecting protein interactions and cellular functions.
• The interaction between Rab27a and Doc2a is crucial for regulating exocytosis.

Purpose of the Study:

• To investigate the effect of zoledronate on histamine release (HR) from RBL-2H3 mast cells.
• To determine if zoledronate impacts the interaction between Rab27a and Doc2a.
• To explore the role of calcium (Ca2+) influx in zoledronate-mediated inhibition of histamine release.

Main Methods:

• Histamine release was quantified using HPLC-fluorometry in RBL-2H3 cells treated with zoledronate or clodronate.
• Cells were stimulated with dinitrophenylated bovine serum albumin (DNP-BSA) or ionomycin.
• Calcium influx was monitored using Fura-2A/M, and Rab27a/Doc2a interaction was assessed via in situ proximity ligation assay (PLA).

Main Results:

• Zoledronate significantly inhibited histamine release from antigen-activated RBL-2H3 cells.
• The inhibitory effect of zoledronate was less pronounced in ionomycin-activated cells.
• Zoledronate did not alter intracellular Ca2+ concentration, Ca2+ influx, or the Rab27a/Doc2a interaction.

Conclusions:

• Zoledronate inhibits histamine release in mast cells, but this effect is independent of Rab27a/Doc2a interaction.
• The mechanism of zoledronate-induced histamine release inhibition does not involve alterations in Ca2+ influx.
• Further research is needed to elucidate the precise prenylated proteins and pathways affected by zoledronate in mast cells.